Showing results (221-230 of 231) with videos related to

Sort By:
Pageof 24
British Journal of Pharmacology|September 1, 1992
Characterization of 8-OH-DPAT-induced hypothermia in mice as a 5-HT1A autoreceptor response and its evaluation as a model to selectively identify antidepressantsK F Martin, I Phillips, M Hearson, et al.
Neuropharmacology|October 22, 2008
Identification of discrete sites of action of chronic treatment with desipramine in a model of neuropathic painK L Jones, D P Finn, R J M Governo, et al.
Neuroscience|January 1, 1982
The effects of monoamine neurotoxins on peptides in the rat spinal cordR F Gilbert, P C Emson, S P Hunt, et al.
The European Journal of Neuroscience|February 27, 2004
Effects of coadministration of cannabinoids and morphine on nociceptive behaviour, brain monoamines and HPA axis activity in a rat model of persistent painD P Finn, S R G Beckett, C H Roe, et al.
British Journal of Pharmacology|March 1, 1993
Mediation of the antidepressant-like effect of 8-OH-DPAT in mice by postsynaptic 5-HT1A receptorsG P Luscombe, K F Martin, L J Hutchins, et al.
Neuropharmacology|September 2, 1999
The effects of the peptide-coupling agent, EEDQ, on 5-HT2A receptor binding and function in rat frontal cortexC J Kettle, S C Cheetham, K F Martin, et al.
Biochemical Pharmacology|October 20, 1992
Qualitative differences in [Ca2+]i increases and InsP3 generation following stimulation of N1E-115 cells with micromolar and millimolar ATPP A Iredale, K F Martin, S P Alexander, et al.
British Journal of Pharmacology|December 1, 1992
Inositol 1,4,5-trisphosphate generation and calcium mobilisation via activation of an atypical P2 receptor in the neuronal cell line, N1E-115P A Iredale, K F Martin, S P Alexander, et al.
British Journal of Pharmacology|October 24, 1998
A comparison of the effects on central 5-HT function of sibutramine hydrochloride and other weight-modifying agentsD J Heal, S C Cheetham, M R Prow, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|October 3, 1998
Sibutramine: a novel anti-obesity drug. A review of the pharmacological evidence to differentiate it from d-amphetamine and d-fenfluramineD J Heal, S Aspley, M R Prow, et al.
Pageof 24